Incoming Novartis CEO On $475,000 Cancer Therapy: ' No Question That The List Price Raises Eyebrows '

Incoming CEO at Swiss drugmaker Novartis, Vas Narasimhan, said he isn ’t interested in following the herd in drug development.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news